PRDM1 and aneurysmal bone cyst: It has been demonstrated that functional PRDM1 is required for mantle cell lymphoma response to bortezomib [117], while loss of PRDM1 was found in more than half of the patients with ABC-DLBCL, which may hinder the apoptosis induced by bortezomib [118].